{"count": 6, "results": [{"_id": "37290186", "pmid": 37290186, "title": "Pleiotropic effects of Salacia reticulata and Simvastatin on oxidative stress and insulin resistance in a rat model.", "journal": "Biomed Pharmacother", "authors": ["Gujjala S", "Bangeppagari M", "Devarakonda VLNP", "Bellamkonda R", "Bhadramraju R", "Kameswaran S", "Ramaswamy R", "Desireddy S"], "date": "2023-08-01T00:00:00Z", "doi": "10.1016/j.biopha.2023.114960", "meta_date_publication": "2023 Aug", "meta_volume": "164", "meta_issue": "", "meta_pages": "114960", "score": 50248.93, "text_hl": "CONCLUSIONS: The present study confirms that SR/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SVS@@@ may be a new and promising remedial approach because of its beneficial effects on the pathophysiological processes of @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@ and related @<m>DISEASE_Metabolic_Diseases</m> @DISEASE_MESH:D008659 @@@metabolic disorders@@@.", "citations": {"NLM": "Gujjala S, Bangeppagari M, Devarakonda VLNP, Bellamkonda R, Bhadramraju R, Kameswaran S, Ramaswamy R, Desireddy S. Pleiotropic effects of Salacia reticulata and Simvastatin on oxidative stress and insulin resistance in a rat model. Biomed Pharmacother. 2023 Aug;164():114960. PMID: 37290186", "BibTeX": "@article{37290186, title={Pleiotropic effects of Salacia reticulata and Simvastatin on oxidative stress and insulin resistance in a rat model.}, author={Gujjala S and Bangeppagari M and Devarakonda VLNP and Bellamkonda R and Bhadramraju R and Kameswaran S and Ramaswamy R and Desireddy S}, journal={Biomed Pharmacother}, volume={164}, pages={114960}}"}}, {"_id": "40971053", "pmid": 40971053, "title": "Folate- and chitosan-functionalized lipid nanoparticles for co-delivery of pioglitazone and simvastatin to enhance hepatic cancer therapy: effects on IL-1beta, IL-6, BCL2/BAX gene expression, and GPX4, COX-2, and MMP-9 activities.", "journal": "Mol Biol Rep", "authors": ["Alzahrani RF", "Almuqati MS", "AlAli SA", "Alamer KA", "Rabbani S", "Alqahtani MS", "Bakheit AH", "Asiri HH", "Harisa GI"], "date": "2025-09-19T00:00:00Z", "doi": "10.1007/s11033-025-11011-2", "meta_date_publication": "2025 Sep 19", "meta_volume": "52", "meta_issue": "1", "meta_pages": "926", "score": 50241.14, "text_hl": "@CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@Pioglitazone@@@ (@CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@PIO@@@) and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@STAT@@@), originally used for @<m>DISEASE_Metabolic_Diseases</m> @DISEASE_MESH:D008659 @@@metabolic disorders@@@, also modulate oncogenic pathways. ", "citations": {"NLM": "Alzahrani RF, Almuqati MS, AlAli SA, Alamer KA, Rabbani S, Alqahtani MS, Bakheit AH, Asiri HH, Harisa GI. Folate- and chitosan-functionalized lipid nanoparticles for co-delivery of pioglitazone and simvastatin to enhance hepatic cancer therapy: effects on IL-1beta, IL-6, BCL2/BAX gene expression, and GPX4, COX-2, and MMP-9 activities. Mol Biol Rep. 2025 Sep 19;52(1):926. PMID: 40971053", "BibTeX": "@article{40971053, title={Folate- and chitosan-functionalized lipid nanoparticles for co-delivery of pioglitazone and simvastatin to enhance hepatic cancer therapy: effects on IL-1beta, IL-6, BCL2/BAX gene expression, and GPX4, COX-2, and MMP-9 activities.}, author={Alzahrani RF and Almuqati MS and AlAli SA and Alamer KA and Rabbani S and Alqahtani MS and Bakheit AH and Asiri HH and Harisa GI}, journal={Mol Biol Rep}, volume={52}, number={1}, pages={926}}"}}, {"_id": "22913213", "pmid": 22913213, "title": "Pleiotropic effects of rimonabant and simvastatin on obesity associated multiple metabolic risk factors in rats.", "journal": "Eur Rev Med Pharmacol Sci", "authors": ["Salem NA", "Assaf N", "Ahmed HH"], "date": "2012-06-01T00:00:00Z", "meta_date_publication": "2012 Jun", "meta_volume": "16", "meta_issue": "6", "meta_pages": "797-807", "score": 50053.94, "text_hl": "OBJECTIVES: The present study was undertaken to investigate the effect of @CHEMICAL_Rimonabant @CHEMICAL_MESH:D000077285 @@@rimonabant@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and their combination on @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@ associated @<m>DISEASE_Metabolic_Diseases</m> @DISEASE_MESH:D008659 @@@metabolic disorder@@@ mediators in adult male @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Salem NA, Assaf N, Ahmed HH. Pleiotropic effects of rimonabant and simvastatin on obesity associated multiple metabolic risk factors in rats. Eur Rev Med Pharmacol Sci. 2012 Jun;16(6):797-807. PMID: 22913213", "BibTeX": "@article{22913213, title={Pleiotropic effects of rimonabant and simvastatin on obesity associated multiple metabolic risk factors in rats.}, author={Salem NA and Assaf N and Ahmed HH}, journal={Eur Rev Med Pharmacol Sci}, volume={16}, number={6}, pages={797-807}}"}}, {"_id": "29795329", "pmid": 29795329, "title": "Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin.", "journal": "Oncogene", "authors": ["Abdoul-Azize S", "Buquet C", "Li H", "Picquenot JM", "Vannier JP"], "date": "2018-09-01T00:00:00Z", "doi": "10.1038/s41388-018-0329-6", "meta_date_publication": "2018 Sep", "meta_volume": "37", "meta_issue": "36", "meta_pages": "4979-4993", "score": 50048.406, "text_hl": "Signal transduction and functional studies revealed that both @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@doxorubicin@@@ trigger persistent cytosolic Ca2+ release, thereby stimulating the proapoptotic @GENE_BCL2L11 @GENE_10018 @@@BIM@@@ pathway and mitochondrial Ca2+ overload, which are responsible for @<m>DISEASE_Metabolic_Diseases</m> @DISEASE_MESH:D008659 @@@metabolic dysfunction@@@ and apoptosis induction. ", "citations": {"NLM": "Abdoul-Azize S, Buquet C, Li H, Picquenot JM, Vannier JP. Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin. Oncogene. 2018 Sep;37(36):4979-4993. PMID: 29795329", "BibTeX": "@article{29795329, title={Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin.}, author={Abdoul-Azize S and Buquet C and Li H and Picquenot JM and Vannier JP}, journal={Oncogene}, volume={37}, number={36}, pages={4979-4993}}"}}, {"_id": "29152896", "pmid": 29152896, "pmcid": "PMC5803604", "title": "Trimetazidine restores the positive adaptation to exercise training by mitigating statin-induced skeletal muscle injury", "journal": "J Cachexia Sarcopenia Muscle", "authors": ["Song M", "Chen FF", "Li YH", "Zhang L", "Wang F", "Qin RR", "Wang ZH", "Zhong M", "Tang MX", "Zhang W", "Han L"], "date": "2018-02-01T00:00:00Z", "doi": "10.1002/jcsm.12250", "meta_date_publication": "2018 Feb", "meta_volume": "9", "meta_issue": "1", "meta_pages": "106-118", "score": 50046.96, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ induced energy @<m>DISEASE_Metabolic_Diseases</m> @DISEASE_MESH:D008659 @@@metabolism dysfunction@@@ of skeletal muscle", "citations": {"NLM": "Song M, Chen FF, Li YH, Zhang L, Wang F, Qin RR, Wang ZH, Zhong M, Tang MX, Zhang W, Han L. Trimetazidine restores the positive adaptation to exercise training by mitigating statin-induced skeletal muscle injury J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):106-118. PMID: 29152896", "BibTeX": "@article{29152896, title={Trimetazidine restores the positive adaptation to exercise training by mitigating statin-induced skeletal muscle injury}, author={Song M and Chen FF and Li YH and Zhang L and Wang F and Qin RR and Wang ZH and Zhong M and Tang MX and Zhang W and Han L}, journal={J Cachexia Sarcopenia Muscle}, volume={9}, number={1}, pages={106-118}}"}}, {"_id": "18718120", "pmid": 18718120, "title": "Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.", "journal": "J Pharm Pharmacol", "authors": ["Arulmozhi DK", "Kurian R", "Bodhankar SL", "Veeranjaneyulu A"], "date": "2008-09-01T00:00:00Z", "doi": "10.1211/jpp.60.9.0008", "meta_date_publication": "2008 Sep", "meta_volume": "60", "meta_issue": "9", "meta_pages": "1167-73", "score": 50033.02, "text_hl": "We have evaluated the effect of various antidiabetic and @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ lowering agents (@CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@, @CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@, @CHEMICAL_glimepiride @CHEMICAL_MESH:C057619 @@@glimepiride@@@, @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@) on the @<m>DISEASE_Metabolic_Diseases</m> @DISEASE_MESH:D008659 @@@metabolic abnormalities@@@ induced by combining a high-fat diet and multiple low-dose @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@streptozocin@@@ (MLDS) in @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Arulmozhi DK, Kurian R, Bodhankar SL, Veeranjaneyulu A. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes. J Pharm Pharmacol. 2008 Sep;60(9):1167-73. PMID: 18718120", "BibTeX": "@article{18718120, title={Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.}, author={Arulmozhi DK and Kurian R and Bodhankar SL and Veeranjaneyulu A}, journal={J Pharm Pharmacol}, volume={60}, number={9}, pages={1167-73}}"}}]}